U.S. market Closed. Opens in 8 hours 13 minutes

ENTXW | Entera Bio Ltd. WT EXP 062723 Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
RevenueN/A134.00K571.00K365.00K236.00K500.00KN/AN/AN/A
Cost of Revenue56.00K101.00K373.00K209.00K210.00KN/AN/AN/AN/A
Gross Profit-56.00K33.00K198.00K156.00K26.00K500.00KN/AN/AN/A
Operating Expenses8.86M13.05M12.41M11.29M11.48M11.36M11.34M5.37M3.70M
Selling, General & Admin4.43M7.25M5.69M4.89M4.28M2.84M8.57M2.72M1.59M
Research & Development4.51M5.85M6.77M6.40M7.20M8.52M2.77M2.65M2.12M
Other Operating ExpensesN/A-51.00K-46.00K1.24M743.00K523.00KN/AN/AN/A
Operating Income-8.89M-13.02M-12.22M-11.13M-11.45M-10.86M11.34M-5.37M-3.70M
Other Expenses / Income31.00K83.00K-29.00K1.17M659.00K523.00K-22.54M4.17M-581.00K
Before Tax Income-8.86M-12.93M-12.25M-9.96M-10.79M-10.30M-11.20M-1.20M-4.28M
Income Tax Expenses29.00K137.00K-59.00K20.00K84.00K557.00KN/AN/AN/A
Net Income-8.89M-13.07M-12.19M-9.98M-10.88M-10.30M-11.20M-1.20M-4.28M
Interest ExpensesN/A-26.00M29.00K28.00K84.00KN/AN/AN/AN/A
Basic Shares Outstanding29.01M28.81M26.13M18.42M12.15M7.98MN/AN/AN/A
Diluted Shares Outstanding29.01M28.81M26.13M18.42M12.15M7.98MN/AN/AN/A
EBITDA-8.84M-13.02M-12.16M-11.13M-11.22M-10.81M-11.15M-5.33M-3.67M
EBITDA Margin0.00%-9,714.18%-2,130.30%-3,050.14%-4,752.54%-2,161.40%0.00%0.00%0.00%
EBIT-8.86M-38.94M-12.22M-9.94M-10.71M-9.75M-11.20M-1.20M-4.28M
EBIT Margin0.00%-29,056.72%-2,139.58%-2,721.92%-4,538.56%-1,949.40%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙